Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.reumae.2020.05.002 http://scihub22266oqcxt.onion/10.1016/j.reumae.2020.05.002 C7561336!7561336!34625144     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Reumatol+Clin+(Engl+Ed) 2021 ; 17 (8): 431-6 Nephropedia Template TP {{tp|p=34625144|t=2021. Therapeutic options for the management of severe COVID-19: A rheumatology perspective? |pdf=|usr=}}{{34625144}} gab.com Text Therapeutic options for the management of severe COVID-19: A rheumatology perspective JO: Reumatol Clin (Engl Ed) http://www.kidney.de/pget.php?&tw=1&pmid=34625144 #FOAvip The novel SARS-CoV-2 human coronavirus in Wuhan, China, has triggered a worldwide respiratory disease outbreak (COVID-19). Acute respiratory distress syndrome (ARDS), multiorgan dysfunction and thrombotic events are among the leading causes of death in critically ill patients with COVID-19. The elevated inflammatory cytokines suggest that a ?cytokine storm?, also known as cytokine release syndrome (CRS), may play a major role in the pathology of COVID-19. In addition to anti-viral therapy and supportive treatment in critically ill patients, unique medications for this condition are also under investigation. Here we reviewed therapeutic options, including the antibody therapy that might be an immediate strategy for SARS-CoV-2 therapy. Twit Text FOAVip Therapeutic options for the management of severe COVID-19: A rheumatology perspective ????Reumatol Clin (Engl Ed) http://www.kidney.de/pget.php?&tw=1&pmid=34625144 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34625144 #FOAvip English Wikipedia <ref>{{Cite pmid|34625144}}</ref> Therapeutic options for the management of severe COVID-19: A rheumatology perspective? #MMPMID34625144 Mendoza-Pinto C; García-Carrasco M; Munguía Realpozo P; Méndez-Martínez S Reumatol Clin (Engl Ed) 2021[Oct]; 17 (8): 431-6 PMID34625144show ga The novel SARS-CoV-2 human coronavirus in Wuhan, China, has triggered a worldwide respiratory disease outbreak (COVID-19). Acute respiratory distress syndrome (ARDS), multiorgan dysfunction and thrombotic events are among the leading causes of death in critically ill patients with COVID-19. The elevated inflammatory cytokines suggest that a ?cytokine storm?, also known as cytokine release syndrome (CRS), may play a major role in the pathology of COVID-19. In addition to anti-viral therapy and supportive treatment in critically ill patients, unique medications for this condition are also under investigation. Here we reviewed therapeutic options, including the antibody therapy that might be an immediate strategy for SARS-CoV-2 therapy. äTherapeutic options for the management of severe COVID-19: A rheumatol(epmc).pdf DeepDyve Pubget Overpricing